Added to YB: 2024-04-20
Pitch date: 2024-04-20
TMDX:US [bearish]
TransMedics Group, Inc.
-58.17%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.6B
Pitch Price
$84.01
Price Target
N/A
Dividend
N/A
EV/EBITDA
36.30
P/E
52.77
EV/Sales
8.17
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
TransMedics Group, Inc. TMDX:US
A summary for this pitch has not been created yet.
Read full article (0 min)